Is contrast material needed after treatment of malignant lymphoma in positron emission tomography/computed tomography?

Is contrast material needed after treatment of malignant lymphoma in positron emission tomography/computed tomography?

  • نوع فایل : کتاب
  • زبان : انگلیسی
  • مؤلف : Yuji Nakamoto Munenobu Nogami Ryo Sugihara Kazuro Sugimura Michio Senda Kaori Togashi
  • چاپ و سال / کشور: 2010

Description

Purpose Positron emission tomography (PET)/computed tomography (CT) with 18F-fluorodeoxyglucose is widely used for post-therapeutic surveillance of malignant lymphoma. Debate still exists as to whether intravenous contrast media during the CT stage of a PET/CT scan should be used. The purpose of this study was to investigate the clinical value of contrast agent in PET/CT in patients with lymphoma following treatment. Patients and methods One hundred and twenty-two consecutive patients with malignant lymphoma underwent 146 PET/CT scans to monitor therapeutic response (n = 57) or surveillance during follow-up (n = 89). All patients had a conventional PET/CT scan with low-dose CT without contrast (ldCT), and then a full-dose CT scan with contrast (ceCT). Two datasets were interpreted separately and prevalence of discrepant results between the two methods was evaluated. In addition, differences of diagnostic performance were investigated for restaging. Results Both PET ? ldCT and PET ? ceCT were positive in 22 cases and negative in 35 cases when monitoring response to therapy. There were no cases in which these techniques demonstrated inconsistent findings. For restaging, the patient-based sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of PET ? ldCT were 70, 91, 76, 87, and 84%, respectively, and those of PET ? ceCT were 74, 92, 81, 89, and 87%, respectively. Discrepant results between the two methods occurred in only 2 of 89 cases (2%). Conclusion PET/ceCT yielded more accurate findings than PET/ldCT in a limited number of cases. PET/ldCT may, therefore, be sufficient for routine PET/CT scanning for post-therapeutic assessment or restaging of lymphoma patients.
Ann Nucl Med (2011) 25:93–99 DOI 10.1007/s12149-010-0429-z Received: 2 August 2010 / Accepted: 15 September 2010 / Published online: 19 October 2010
اگر شما نسبت به این اثر یا عنوان محق هستید، لطفا از طریق "بخش تماس با ما" با ما تماس بگیرید و برای اطلاعات بیشتر، صفحه قوانین و مقررات را مطالعه نمایید.

دیدگاه کاربران


لطفا در این قسمت فقط نظر شخصی در مورد این عنوان را وارد نمایید و در صورتیکه مشکلی با دانلود یا استفاده از این فایل دارید در صفحه کاربری تیکت ثبت کنید.

بارگزاری